BLT 0.00% 2.6¢ benitec biopharma limited

Ann: OPMD ORPHAN DISEASE PROGRAM ADVANCEMENT, page-22

  1. 536 Posts.
    lightbulb Created with Sketch. 1
    I think the following quote from our OPMD press release is very promising...

    "Similar application of the single vector technology may allow development of novel therapeutics to treat other orphan diseases. " Greg West
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.